INSIGHTS ON DRUG DEVELOPMENT
-
Unravelling Immunological Depths: Exploring Oxazolone-Induced Delayed-Type Hypersensitivity Model
Validating the oxazolone-induced DTH mouse model offers a critical platform for advancing the evaluation of therapeutic candidates for chronic inflammatory diseases, including atopic dermatitis.
-
Comprehensive Workflow For The Quantification Of Peptides And Proteins
Biologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.
-
Column Selection For RPLC-UV Impurity Analysis
Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.
-
Optimized And Scalable LNP Composition For RNA Vaccine Delivery
Explore results from a study screening novel LNP formulations for physicochemical attributes, in vitro potency, and in vivo immunogenicity in both SARS-CoV-2 and influenza vaccine applications.
-
Epigenetics Application Guide10/2/2024
To fully understand biology and disease mechanisms, it is crucial to explore the role of epigenetic factors. Explore how epigenetic regulation works and methods to study these essential components.
-
Surface Plasmon Resonance for Biomolecular Interaction Analysis4/15/2025
Explore how uncovering molecular interactions can drive breakthroughs in disease understanding, drug discovery, and therapeutic innovation.
-
Effect Of Methylprednisolone On The Systemic Lupus Erythematosus (SLE) In Murine Models5/13/2025
Leverage the MRL/lpr lupus mouse model to evaluate the effectiveness of potential SLE treatments, like Methylprednisolone, in managing key symptoms such as proteinuria and autoimmune responses.
-
Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery6/3/2025
Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.
-
Advancing Cell Therapies With Lipid Nanoparticles3/24/2025
Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.
DRUG DEVELOPMENT SOLUTIONS
-
Leica S9 I Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica
-
Accelerate your research and development with high-quality, custom phosphoramidite synthesis backed by decades of proven chemistry and scalable precision.
-
Explore a diverse range of HPLC and UHPLC columns from a comprehensive portfolio of analytical solutions, and learn how to select the right column for the right separation.
-
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.
-
Unlock precision and flexibility with an affordable, high-performance solution for absorbance, fluorescence, and luminescence assays, with advanced upgrades for live-cell analysis.